Remaining measles challenges in Australia

David N Durrheim, Heath Kelly, Mark J Ferson and David Featherstone
Med J Aust 2007; 187 (3): 181-184.
  • David N Durrheim1
  • Heath Kelly2,3
  • Mark J Ferson4,5
  • David Featherstone6

  • 1 Hunter New England Population Health, Hunter New England Area Health Service, Newcastle, NSW.
  • 2 Epidemiology Unit, Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC.
  • 3 School of Population Health, University of Melbourne, Melbourne, VIC.
  • 4 Public Health Unit, South Eastern Sydney and Illawarra Area Health Service, Wollongong, NSW.
  • 5 School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW.
  • 6 Vaccine-Preventable Disease Laboratory Network, Expanded Programme for Immunization, World Health Organization, Geneva, Switzerland.


We thank Dr Michaela Riddell, National Health and Medical Research Council Sidney Sax Fellow, and Senior Laboratory Epidemiologist, Victorian Infectious Diseases Reference Laboratory, for constructive comments on a draft of this manuscript.

Competing interests:

None identified.

  • 1. Tobin S, Kelly H. Measles encephalitis in Victoria: down but not out. Aust N Z J Public Health 1999; 23: 443.
  • 2. Anderson RM, May RM. Infectious diseases of humans. Dynamics and control. Oxford: Oxford University Press, 1992: 70.
  • 3. Gidding HF, Wood J, MacIntyre CR, et al. Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine 2007; 25: 3574-3580.
  • 4. Strebel P, Cochi S, Grabowsky M, et al. The unfinished measles immunization agenda. J Infect Dis 2003; 187 Suppl 1: S1–S7.
  • 5. Communicable Diseases Report for New South Wales for March and April 2006. N S W Public Health Bull 2006; 17: 88–94.
  • 6. Gidding HF. The impact of Australia’s measles control programme over the past decade. Epidemiol Infect 2005; 133: 99-105.
  • 7. Wood DL, Brunell PA. Measles control in the United States: problems of the past and challenges for the future. Clin Microbiol Rev 1995; 8: 260-267.
  • 8. Kremer JR, Schneider F, Muller CP. Waning antibodies in measles and rubella vaccines — a longitudinal study. Vaccine 2006; 24: 2594-2601.
  • 9. Riddell MA, Lynch P, Jin L, Chibo D. Measles case imported from Europe to Victoria, Australia, March 2006. Euro Surveill 2006; 11: E060518.2.
  • 10. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004; 189 Suppl 1: S4-S16.
  • 11. Lambert SB, Kelly HA, Andrews RM, et al. Enhanced measles surveillance during an interepidemic period in Victoria. Med J Aust 2000; 172: 114-118. <MJA full text>
  • 12. Weber DJ, Cohen MS, Fine J-D. The acutely ill patient with fever and rash. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s principles and practice of infectious disease. 5th ed. Philadelphia: Churchill Livingstone, 2000: 633-650.
  • 13. Scott LA, Stone MS. Viral exanthems. Dermatol Online J 2003; 9: 4.
  • 14. Ferson MJ, Young LC, Robertson PW, Whybin LR. Difficulties in the clinical diagnosis of measles: proposal for modified clinical case definition. Med J Aust 1995; 163: 364-366.
  • 15. Wang YJ, Andrews RM, Lambert SB. Measles surveillance in Victoria, Australia. Bull World Health Organ 2006; 84: 105-111.
  • 16. Dayan GH, Ortega-Sanchez IR, LeBaron CW, Quinlisk MP; Iowa Measles Response Team. The cost of containing one case of measles: the economic impact on the public health infrastructure — Iowa, 2004. Pediatrics 2005: 116: e1-e4.
  • 17. Monitoring the interruption of indigenous measles transmission, Cape Town meeting, 14 October 2003. Wkly Epidemiol Rec 2004; 79: 70-72.
  • 18. Kelly H, Leydon J. Outbreaks caused by parvovirus B19. Euro Surveill 2005; 10: E1-E2.
  • 19. Dietz V, Rota J, Izurieta H, et al. The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas. Bull World Health Organ 2004; 82: 852-857.
  • 20. Jenkin GA, Chibo D, Kelly H, et al. What is the cause of rash in a child following measles–mumps–rubella vaccination? Med J Aust 1999; 171: 194-197.
  • 21. Riddell M, Chibo D, Kelly HA, et al. Investigation of optimal specimen type and sampling time for the detection of measles virus RNA during a measles epidemic. J Clin Microbiol 2001; 39: 375-376.
  • 22. Featherstone D, Brown D, Sanders R. Development of the Global Measles Laboratory Network. J Infect Dis 2003; 187 Suppl 1: S264-S269.
  • 23. National Health and Medical Research Council. The Australian immunisation handbook. 8th ed. Canberra: Australian Government Department of Health and Ageing, 2003: 155. (accessed Jun 2007).
  • 24. Ferson MJ, Young LC, Robertson PW, Whybin LR. Difficulties in clinical diagnosis of measles: proposal for modified clinical case definition. Med J Aust 1995; 163: 364-366.
  • 25. National Health and Medical Research Council. Staying healthy in child care. Preventing infectious diseases in child care. 4th ed. Canberra: NHMRC, 2005: 8. (accessed Jun 2007).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.